Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering

Abstract Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. Howe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kevin M. Blum, Lauren C. Roby, Jacob C. Zbinden, Yu-Chun Chang, Gabriel J. M. Mirhaidari, James W. Reinhardt, Tai Yi, Jenny C. Barker, Christopher K. Breuer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/e7de3cbd0e39491ab82f2557cb8e8c1f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e7de3cbd0e39491ab82f2557cb8e8c1f
record_format dspace
spelling oai:doaj.org-article:e7de3cbd0e39491ab82f2557cb8e8c1f2021-12-02T14:26:16ZSex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering10.1038/s41598-021-87006-32045-2322https://doaj.org/article/e7de3cbd0e39491ab82f2557cb8e8c1f2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87006-3https://doaj.org/toc/2045-2322Abstract Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here we describe the importance of challenging the baseline assumption that tamoxifen is inert when used as a small molecule inducer in the context of cardiovascular tissue engineering. Employing a standard inferior vena cava vascular interposition graft model in C57BL/6 mice, we discovered differences in the immunologic response between control and tamoxifen-treated animals, including occlusion rate, macrophage infiltration and phenotype, the extent of foreign body giant cell development, and collagen deposition. Further, differences were noted between untreated males and females. Our findings demonstrate that the host-response to materials commonly used in cardiovascular tissue engineering is sex-specific and critically impacted by exposure to tamoxifen, necessitating careful model selection and interpretation of results.Kevin M. BlumLauren C. RobyJacob C. ZbindenYu-Chun ChangGabriel J. M. MirhaidariJames W. ReinhardtTai YiJenny C. BarkerChristopher K. BreuerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Kevin M. Blum
Lauren C. Roby
Jacob C. Zbinden
Yu-Chun Chang
Gabriel J. M. Mirhaidari
James W. Reinhardt
Tai Yi
Jenny C. Barker
Christopher K. Breuer
Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
description Abstract Tissue engineered vascular grafts hold promise for the creation of functional blood vessels from biodegradable scaffolds. Because the precise mechanisms regulating this process are still under investigation, inducible genetic mouse models are an important and widely used research tool. However, here we describe the importance of challenging the baseline assumption that tamoxifen is inert when used as a small molecule inducer in the context of cardiovascular tissue engineering. Employing a standard inferior vena cava vascular interposition graft model in C57BL/6 mice, we discovered differences in the immunologic response between control and tamoxifen-treated animals, including occlusion rate, macrophage infiltration and phenotype, the extent of foreign body giant cell development, and collagen deposition. Further, differences were noted between untreated males and females. Our findings demonstrate that the host-response to materials commonly used in cardiovascular tissue engineering is sex-specific and critically impacted by exposure to tamoxifen, necessitating careful model selection and interpretation of results.
format article
author Kevin M. Blum
Lauren C. Roby
Jacob C. Zbinden
Yu-Chun Chang
Gabriel J. M. Mirhaidari
James W. Reinhardt
Tai Yi
Jenny C. Barker
Christopher K. Breuer
author_facet Kevin M. Blum
Lauren C. Roby
Jacob C. Zbinden
Yu-Chun Chang
Gabriel J. M. Mirhaidari
James W. Reinhardt
Tai Yi
Jenny C. Barker
Christopher K. Breuer
author_sort Kevin M. Blum
title Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_short Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_full Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_fullStr Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_full_unstemmed Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering
title_sort sex and tamoxifen confound murine experimental studies in cardiovascular tissue engineering
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e7de3cbd0e39491ab82f2557cb8e8c1f
work_keys_str_mv AT kevinmblum sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT laurencroby sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT jacobczbinden sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT yuchunchang sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT gabrieljmmirhaidari sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT jameswreinhardt sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT taiyi sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT jennycbarker sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
AT christopherkbreuer sexandtamoxifenconfoundmurineexperimentalstudiesincardiovasculartissueengineering
_version_ 1718391402653548544